HCPCS Codes Similar to V4

HCPCS Codes Similar to “V4” Code.
Demonstration modifier 4

V1 Demonstration modifier 1 Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON	V2 Demonstration modifier 2 Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON
V3 Demonstration modifier 3 Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON	G9066 Oncology; disease status; limited to non-small cell lung cancer; stage iii b- iv at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project) Code added date: 20060101 Code effective date: 20070101 TXT \| PDF \| XML \| JSON
G9086 Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-4, n1-2, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) Code added date: 20060101 Code effective date: 20070101 TXT \| PDF \| XML \| JSON	G9110 Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease initially established as t3-4 and/or n1-3, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) Code added date: 20060101 Code effective date: 20070101 TXT \| PDF \| XML \| JSON
G9115 Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage iii-iv; without evidence of progression, recurrence, or metastases (for use in a medicare-approved demonstration project) Code added date: 20060101 Code effective date: 20070101 TXT \| PDF \| XML \| JSON	G9135 Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; stage iii, iv, not relapsed, not refractory (for use in a medicare-approved demonstration project) Code added date: 20070101 Code effective date: 20070101 TXT \| PDF \| XML \| JSON
G9140 Frontier extended stay clinic demonstration; for a patient stay in a clinic approved for the cms demonstration project; the following measures should be present: the stay must be equal to or greater than 4 hours; weather or other conditions must prevent transfer or the case falls into a category of monitoring and observation cases that are permitted by the rules of the demonstration; there is a maximum frontier extended stay clinic (fesc) visit of 48 hours, except in the case when weather or other conditions prevent transfer; payment is made on each period up to 4 hours, after the first 4 hours Code added date: 20071001 Code effective date: 20071001 TXT \| PDF \| XML \| JSON	A9612 Injection, fluorescein, 1 mg Code added date: 20251001 Code effective date: 20251001 TXT \| PDF \| XML \| JSON
A9616 Gallium ga-68 gozetotide (gozellix), diagnostic, 1 millicurie Code added date: 20251001 Code effective date: 20251001 TXT \| PDF \| XML \| JSON	G0248 Demonstration, prior to initiation of home inr monitoring, for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria, under the direction of a physician; includes: face-to-face demonstration of use and care of the inr monitor, obtaining at least one blood sample, provision of instructions for reporting home inr test results, and documentation of patient's ability to perform testing and report results Code added date: 20020701 Code effective date: 20080319 TXT \| PDF \| XML \| JSON
G2172 All inclusive payment for services related to highly coordinated and integrated opioid use disorder (oud) treatment services furnished for the demonstration project Code added date: 20210401 Code effective date: 20210401 TXT \| PDF \| XML \| JSON	G9017 Amantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project) Code added date: 20041201 Code effective date: 20200101 TXT \| PDF \| XML \| JSON